556 Establishment of a novel preclinical model for evaluating immune checkpoint blockade-induced antitumor immunological memory in lung cancer

556 Establishment of a novel preclinical model for evaluating immune checkpoint blockade-induced antitumor immunological memory in lung cancer

Bibliographic Details
Main Authors:	Ichiro Kinoshita, Takuro Noguchi, Hitoki Arisato, Akihiko Shiiya, Hirotoshi Akita
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
by: Adrià Archilla-Ortega, et al.
Published: (2022-02-01)

Combination of immune checkpoint blockade and targeted gene regulation of angiogenesis for facilitating antitumor immunotherapy
by: Jing Zhan, et al.
Published: (2023-03-01)

Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade
by: Xuewei Bai, et al.
Published: (2022-04-01)

TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
by: Alice L. Hung, et al.
Published: (2018-08-01)

Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma
by: Kimberly Loo, et al.
Published: (2022-01-01)

Karabinek reprezentacyjny MSBS-5,56R systemu MSBS-5,56
by: Ryszard WOŹNIAK, et al.
Published: (2018-09-01)

Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations
by: Nicola Principe, et al.
Published: (2022-05-01)

Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune “cold” tumors
by: Guixiu Xiao, et al.
Published: (2023-10-01)

In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade
by: Veronique Beiss, et al.
Published: (2022-12-01)

Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade
by: Yang Liu, et al.
Published: (2020-12-01)

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
by: Guru Sonpavde, et al.
Published: (2021-11-01)

Meta-analysis of preclinical measures of efficacy in immune checkpoint blockade therapies and comparison to clinical efficacy estimates
by: Juan Miguel Tenorio-Pedraza, et al.
Published: (2023-08-01)

1064 Characterization of preclinical anti-tumor and pharmacodynamic activity in response to conditionally active IFNa with or without checkpoint blockade
by: Alexey Berezhnoy, et al.
Published: (2023-11-01)

Intralesional administration of VAX014 facilitates in situ immunization and potentiates immune checkpoint blockade in immunologically cold tumors
by: Shingo Tsuji, et al.
Published: (2023-06-01)

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
by: Lopes, A, et al.
Published: (2018)

Motility Dynamics of T Cells in Tumor-Draining Lymph Nodes: A Rational Indicator of Antitumor Response and Immune Checkpoint Blockade
by: Yasuhiro Kanda, et al.
Published: (2021-09-01)

Systemic inflammation shapes clinical outcomes in response to immune checkpoint blockade treatment: moving toward optimizing antitumor immunity
by: Ming Zheng
Published: (2023-03-01)

Nanoformulation improves antitumor efficacy of MAOI immune checkpoint blockade therapy without causing aggression-related side effects
by: James Brown, et al.
Published: (2022-09-01)

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
by: Alessandra Lopes, et al.
Published: (2018-10-01)

MCT4 blockade increases the efficacy of immune checkpoint blockade
by: Christian Schmidl, et al.
Published: (2023-10-01)

MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
by: Nabanita Mukherjee, et al.
Published: (2024-03-01)

Enhanced synergistic antitumor effect of a DNA vaccine with anticancer cytokine, MDA-7/IL-24, and immune checkpoint blockade
by: Seyed Mohammad Miri, et al.
Published: (2022-06-01)

Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
by: Shahram Salek-Ardakani, et al.
Published: (2021-10-01)

Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity
by: Xiao Yang, et al.
Published: (2022-01-01)

Immune-Checkpoint Blockade Therapy in Lymphoma
by: Ayumi Kuzume, et al.
Published: (2020-07-01)

48218 Preclinical modeling of BRAF(V600E)/PTEN-/- melanoma leptomeningeal disease (LMD) to assess intrathecal checkpoint blockade
by: Renato A. Guerrieri, et al.
Published: (2021-03-01)

RMT 556 - PENGURUSAN DAN ORGANISASI PROJEK
by: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Published: (2005)

PLG 556 - PENILAIAN INDIVIDU MAC 05.
by: PPIP, Pusat Pengajian Ilmu Pendidikan
Published: (2005)

Industrial roof : design sheet 550 - 556
by: 10769 Timber Research and Development Association (Great Britain)
Published: ([19-)

Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
by: Naoki Hama, et al.
Published: (2020-10-01)

The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy
by: Lidy Vannessa Mejía-Guarnizo, et al.
Published: (2023-12-01)

Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy
by: Jiali Luo, et al.
Published: (2022-05-01)

Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy
by: Zhao P, et al.
Published: (2021-03-01)

Preclinical evaluation of discorhabdin in antiangiogenic and antitumor models
by: Harris, E, et al.
Published: (2018)

Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models
by: Emily M. Harris, et al.
Published: (2018-07-01)

The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies
by: Ombretta Melaiu, et al.
Published: (2023-02-01)

Antitumor effects of TIM‐1 blockade in B cells
by: Wenwen Liu, et al.
Published: (2024-03-01)

CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015-10-01)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
by: Jan Christoph Banck, et al.
Published: (2021-03-01)

Acquired Resistance to Immune Checkpoint Blockade Therapies
by: Xianda Zhao, et al.
Published: (2020-05-01)